nVerses Capital LLC Takes $1.08 Million Position in The Clorox Company (NYSE:CLX)

nVerses Capital LLC purchased a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor purchased 6,600 shares of the company's stock, valued at approximately $1,075,000. Clorox comprises about 0.5% of nVerses Capital LLC's investment portfolio, making the stock its 17th largest holding.

Several other hedge funds also recently added to or reduced their stakes in CLX. Fisher Asset Management LLC grew its holdings in Clorox by 2.2% during the 4th quarter. Fisher Asset Management LLC now owns 22,966 shares of the company's stock valued at $3,275,000 after purchasing an additional 493 shares during the last quarter. HighPoint Advisor Group LLC bought a new position in Clorox during the 4th quarter valued at about $412,000. Los Angeles Capital Management LLC grew its holdings in Clorox by 268.7% during the 1st quarter. Los Angeles Capital Management LLC now owns 192,982 shares of the company's stock valued at $29,547,000 after purchasing an additional 140,642 shares during the last quarter. GAMMA Investing LLC grew its holdings in Clorox by 15.8% during the 1st quarter. GAMMA Investing LLC now owns 952 shares of the company's stock valued at $146,000 after purchasing an additional 130 shares during the last quarter. Finally, Alaska Permanent Fund Corp bought a new position in Clorox during the 1st quarter valued at about $63,000. 78.53% of the stock is currently owned by institutional investors.

Insider Activity at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the firm's stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.51% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

CLX has been the subject of several research reports. TD Cowen initiated coverage on shares of Clorox in a research report on Tuesday, July 23rd. They issued a "sell" rating and a $122.00 price objective for the company. Barclays boosted their price objective on shares of Clorox from $130.00 to $137.00 and gave the company an "underweight" rating in a research report on Friday, October 11th. BNP Paribas raised shares of Clorox to a "strong sell" rating in a research report on Friday, September 6th. Evercore ISI lowered their price target on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a research report on Monday. Finally, Citigroup upped their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Six equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $150.14.

Clorox Stock Performance

Shares of Clorox stock traded down $0.82 during trading on Thursday, hitting $162.61. 664,082 shares of the company's stock were exchanged, compared to its average volume of 1,233,369. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The business has a 50-day simple moving average of $158.90 and a 200-day simple moving average of $145.10. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.09. The stock has a market capitalization of $20.19 billion, a price-to-earnings ratio of 84.25, a PEG ratio of 3.19 and a beta of 0.41.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.54 by $0.28. The company had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. On average, research analysts forecast that The Clorox Company will post 6.64 EPS for the current year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 3.00%. Clorox's dividend payout ratio is presently 252.85%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.